Thoratec Corporation

Skip to content

VAD Trials & Outcomes

Momentum llI Logo

HeartMate III™ Clinical Trial

HeartMate III

The MOMENTUM III trial is a prospective, multi-center, unblended randomized study comparing the HeartMate III Left Ventricular Assist System (LVAS) to the HeartMate II LVAS in advanced stage heart failure patients.

HeartMate II Clinical Trial Results

As Thoratec's first-line intermediate-to-chronic left ventricular assist device, the HeartMate II is the most widely used, extensively studied LVAD in the world as Bridge-to-Transplantation and Destination Therapy (i.e. for patient ineligible for cardiac transplant) for advanced heart failure.

A clinical trial to assess the incidence of HeartMate II® pump thrombosis in the current era when recommended practice for clinical management are adopted and to identify the risk factors associated with pump thrombosis events.

Learn More

Text Size: A A A

See usage guidelines, research articles, and publications for Thoratec products.

Explore Resource Library